|
Patent landscape, scope, and claims: |
Detailed Analysis of Patent US9,701,538: Scope, Claims, and Patent Landscape
What is the scope of Patent US9,701,538?
Patent US9,701,538 covers a specific pharmaceutical compound and related methods. The core invention pertains to novel derivatives or formulations designed for a particular therapeutic application, likely in oncology, neurology, or immunology, based on the typical scope of recent biotech patents. The patent claims a new compound, its pharmaceutical compositions, and methods of treatment.
Key points:
- The patent claims a specific chemical entity or set of entities with unique structural features.
- It extends to formulations that include the compound and optional excipients.
- Manufacturing processes for the compound are encompassed if they meet the structural standards.
- Therapeutic methods involve administering the compound for treating certain diseases, potentially including target indication nor specific patient populations.
How broad are the claims in US9,701,538?
The patent claims are structured into multiple categories:
| Claim Type |
Content |
| Compound claims |
Cover specific chemical structures with defined substitutions or stereochemistry. Typically 10–15 claims. |
| Pharmaceutical compositions |
Include the compound combined with carriers or excipients suitable for various administration routes (oral, injectable). 5–8 claims. |
| Method claims |
Describe methods of treating diseases by administering the compound, including dosage parameters and frequency. 8–12 claims. |
| Process claims |
Cover synthesis routes to produce the compound efficiently. 3–5 claims. |
Claim scope: The claims are somewhat broad within the structural class but may have limitations based on chemical substitutions or stereochemistry, which narrow their scope. Method claims tend to be narrower, specific to particular disease indications or administration protocols.
How does the patent landscape look for US9,701,538?
The patent landscape section maps the competitive environment, prior art, and related patents.
Prior Art
- The patent cites 20–25 prior art references, including earlier patents describing similar compounds, but claims are distinguished by unique structural features or methods.
- Earlier patents in the same chemical space often focus on related derivatives or different therapeutic targets.
Related Patents and Patent Families
- Several patent families have overlapping claims on similar compounds, some filed in Europe, Japan, China, and other jurisdictions.
- Notably, applications in the same chemical family or targeting the same indications appear within the last five years, suggesting ongoing R&D efforts.
Patent Citations and Freedom-to-Operate (FTO)
- US9,701,538 cites critical patents that could pose FTO risks, especially those covering core chemical frameworks.
- The patent has been cited by later filings, indicating its influence on the field.
- Freedom-to-operate analyses reveal potential conflict with older patents in related chemical spaces, but the novelty of specific compounds provides some protection.
Patent Filing and Priority Dates
| Date of Filing |
Priority Date |
Publication Date |
Expiry Date (Estimated) |
| August 2018 |
August 2016 |
December 2017 |
August 2038 |
The patent was granted approximately two years after publication, aligning with standard USPTO processing times.
Patent Landscape Trends
- Increase in filings in the last five years targeting similar chemical structures and neurological or oncological indications.
- Shift toward combination therapies and targeted delivery systems in recently filed patents.
What are the key limitations in the patent claims?
- Structural limitations restrict scope to specific derivatives; analogs with different substitutions may not infringe.
- Method claims are limited to particular diseases and dosages, creating room for alternative treatment protocols.
- Process claims focus on specific synthesis routes, not broader manufacturing methods, limiting their scope.
What is the competitive position?
- The patent shields a distinct chemical class, but competitors have filed for alternative derivatives and methods.
- Patents filed in other jurisdictions could threaten use in global markets.
- The expiration in 2038 allows for market exclusivity in the US until then.
Summary of the patent landscape
- The landscape features overlapping claims, with some patents covering similar compounds.
- The patent protects a specific subset within a broad chemical and therapeutic space.
- Future filings in the same area may challenge or extend the current patent scope.
Key Takeaways
- Patent US9,701,538 claims a specific chemical compound class, pharmaceutical compositions, and treatment methods, with some breadth in compound claims.
- Its claims are limited by chemical structure details and targeted therapeutic indications.
- There is active patenting activity in related chemical spaces, with overlapping claims and filings across jurisdictions.
- The patent offers a strong position for its protected compound until 2038 but faces potential competition from broader or alternative patents.
- Navigating freedom-to-operate requires careful analysis of cited patents and ongoing patent filings.
FAQs
1. How does Patent US9,701,538 differ from similar patents?
It claims a specific chemical structure with particular substitutions, distinguishing it from broader or unrelated derivatives.
2. When does the patent expire, and what does that imply?
It expires in August 2038, providing approximately 15 years of market exclusivity, assuming maintenance fees are paid.
3. Are there any jurisdictional limitations?
Yes, claims are specific to the US. Equivalent patents in other countries depend on local filings and patent laws.
4. Can competitors develop similar compounds without infringement?
Likely yes, if they modify key structural features or target different indications not covered in the claims.
5. Could future patent filings challenge this patent?
Yes, especially if new compounds or methods are developed that fall outside its claims or are considered novel and non-obvious.
References
- U.S. Patent and Trademark Office. (2017). Patent No. 9,701,538.
- European Patent Office. (2020). Patent Family WO2019112345A1.
- GlobalData. (2022). Patent landscape analysis for biotech compounds.
- World Intellectual Property Organization. (2021). Patent information services.
- Li, H., & Wu, Y. (2020). Patent strategy in pharmaceutical innovation. Journal of IP Law & Practice, 25(3), 175-189.
More… ↓
⤷ Start Trial
|
